Pharmaceutical companies organize personnel to participate in drug registration regulations training
Release time:
2021-01-21
Pharmaceutical Company organized personnel to participate in the training of drug registration regulations
In order to publicize and learn relevant policies and technical requirements, keep abreast of the latest legal developments and strengthen communication with the State Administration, on January 15, Pharmaceutical Company organized relevant personnel to participate in the online training of the latest progress report of drug registration regulations.
This training is sponsored by China Drug Supervision and Administration Research Association, and the Drug Registration Administration Department and Drug Evaluation Center of the State Drug Administration are the technical guidance units. It is mainly reported by experts from different drug evaluation centers from the perspectives of the reform progress of drug evaluation and approval system, newly revised supporting documents and work progress of drug registration, relevant requirements of drug post-marketing change management, and planning contents of drug technical guidelines, among them, it focuses on the detailed explanation of the trial version of the "Administrative Measures for Post-marketing Changes of Drugs" issued on January 13, and the formulation plan for the follow-up guiding principles is also explained accordingly.
At the same time, in order to facilitate colleagues from various departments to participate in the training, according to the needs of their respective workplaces, the pharmaceutical company has set up a training venue in Jinxi factory area and Qiubin factory area respectively. Colleagues from product development department, quality assurance department and pharmaceutical factory actively participated in training and online communication, raised questions according to their job requirements and received professional responses from experts. Through this training, the trainees have a deeper understanding of the latest progress of the current drug registration related laws and regulations, which has laid a good foundation for the relevant work in this position. (lu yating, lu ziwei)
More information
In March, the authoritative organization of the cement industry successively released two series of lists of China's top 500 building materials enterprises in 2022 and China's top 100 cement clinker production capacity in 2022. Jianfeng Group ranked among the "top 100" in the two lists ". The list of China's top 500 building materials enterprises was officially released in early March. This series of lists was selected by the China Building Materials Enterprise Management Association. Through more than 20 years of comprehensive data research on China's building materials industry, referring to international practices, the rankings are based on the company's annual operating income., Cement products, building ceramics, waterproof materials, aluminum-plastic profiles, coatings, glass, building materials equipment manufacturing and other sub-industries related to building materials. Jianfeng Group ranks 96th among the companies on the list and 27th among the cement manufacturers on the list. On March 16, the awarding ceremony of 2022 China's top 100 cement clinker production capacity list was held in Hangzhou. This series of lists is released by China Cement Network, an authoritative organization in China's cement industry. The ranking is based on the total production capacity (excluding the production capacity of other kiln types and grinding stations) of new dry clinker production lines completed and put into operation by Chinese cement enterprises in China as of December 31, 2022. The data statistics are calculated based on the design production capacity and 310 days of annual operation. Jianfeng Group ranked 53rd with an annual design capacity of 3.627 million tons. (this newspaper reporter)
2023
03-21
Company sends off retired employees
On the morning of February 22, the trade union of the group company held a simple and warm farewell party for retired employees in 2021-2022. More than 50 retired employees gathered together to discuss and exchange with Jiang Xiaomeng and other group leaders.
2023
03-04
On the first day of the new year, group leaders went to the grassroots level.
On January 29, the first day of work after the Spring Festival holiday, the leaders of the group company made a video connection to subordinate enterprises stationed abroad, and separately visited the gold enterprises to learn about the resumption of work and put forward requirements for the implementation of the work plan for the new year.
2023
02-17
Group Companies Commend 2022 Advanced
On the morning of January 18, the group company held the 2022 annual summary commendation meeting to review the work of the previous year, make arrangements for the work in 2023, sign the 2023 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2022 advanced collectives and individuals.
2023
01-29
Jiang Xiaomeng re-elected chairman of the Municipal Federation of Industry and Commerce
On December 24, 2022, the Jinhua Federation of Industry and Commerce (General Chamber of Commerce) held the seventh member representative meeting. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was re-elected as the chairman of the Municipal Federation of Industry and Commerce at this meeting.
2023
01-12
Peak Pharmaceutical Donates Epidemic Prevention Materials
Since the optimization and adjustment of the new crown infection epidemic management policy, there has been an explosive growth of infected people in the country, and the pressure on the supply of related materials has increased sharply. Before and after New Year's Day, the company has twice organized epidemic prevention materials, through the Jinhua City Charity Federation, Jinhua City Economic and Technological Development Zone Charity Federation targeted donations, a total value of more than 200,000 yuan.
2023
01-12